Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans

Cancer Research

Volumn 63, Issue 15, 2003, Pages 4594-4601

  McGlynn, Katherine A ^a   Hunter, Kent ^a   LeVoyer, Thomas ^b   Roush, Jessica ^a   Wise, Philip ^a   Michielli, Rita A ^b   Shen, Fu Min ^c   Evans, Alison A ^b   London, W Thomas ^b   Buetow, Kenneth H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; AFLATOXIN B1 EXO 8,9 EPOXIDE; EPOXIDE; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; PROTEIN P53; RNA; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DETOXIFICATION; FEMALE; GENE LOCUS; GENOTYPE; HUMAN; INBRED STRAIN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK FACTOR; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; XENOBIOTIC METABOLISM; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; COCARCINOGENESIS; DBA MOUSE; GENETICS; LIVER TUMOR; MIDDLE AGED; MOLECULAR GENETICS; MOUSE MUTANT; TRANSGENIC MOUSE;

AFLATOXIN B1; AMINO ACID SEQUENCE; ANIMALS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; COCARCINOGENESIS; CONSERVED SEQUENCE; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; MICE, TRANSGENIC; MIDDLE AGED; MOLECULAR SEQUENCE DATA;

EID: 0042635848     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Parkin, D. M., Bray, F., Ferlay, J., and Pisani, P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer, 94: 153-156, 2001.
2. London, W. T., Evans, A. A., McGlynn, K., Buetow, K., An, P., Gao, L., Lustbader, E., Ross, E., Chen, G., and Shen, F. Viral, host and environmental risk factors for hepatocellular carcinoma: a prospective study in Haimen City, China. Intervirology, 38: 155-161, 1995.
3. Garner, R. C., Miller, E. C., and Miller, J. A. Liver microsomal metabolism of aflatoxin B 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530. Cancer Res., 32: 2058-2066, 1972.
4. Foster, P. L., Eisenstadt, E., and Miller, J. H. Base substitution mutations induced by metabolically activated aflatoxin B1. Proc. Natl. Acad. Sci. USA, 80: 2695-2698, 1983.
5. Qian, G. S., Ross, R. K., Yu, M. C., Yuan, J. M., Gao, Y. T., Henderson, B. E., Wogan, G. N., and Groopman, J. D. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol. Biomark. Prev., 3: 3-10, 1994.
6. McGlynn, K. A., Rosvold, E. A., Lustbader, E. D., Hu, Y., Clapper, M. L., Zhou, T., Wild, C. P., Xia, X. L., Baffoe-Bonnie, A., Ofori-Adjei, D., et al. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc. Natl. Acad. Sci. USA, 92: 2384-2387, 1995.
7. Yu, M. W., Gladek-Yarborough, A., Chiamprasert, S., Santella, R. M., Liaw, Y. F., and Chen, C. J. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology, 109: 1266-1273, 1995.
8. Chen, C. J., Yu, M. W., Liaw, Y. F., Wang, L. W., Chiamprasert, S., Matin, F., Hirvonen, A., Bell, D. A., and Santella, R. M. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am. J. Hum. Genet., 59: 128-134, 1996.
9. Hsieh, L. L., Huang, R. C., Yu, M. W., Chen, C. J., and Liaw, Y. F. L-Myc, GST M1 genetic polymorphism and hepatocellular carcinoma risk among chronic hepatitis B carriers. Cancer Lett., 103: 171-176, 1996.
10. Yu, M. W., Chiu, Y. H., Chiang, Y. C., Chen, C. H., Lee, T. H., Santella, R. M., Chern, H. D., Liaw, Y. F., and Chen, C. J. Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: independent and interactive effects. Am. J. Epidemiol., 149: 621-629, 1999.
11. Sun, C. A., Wang, L. Y., Chen, C. J., Lu, S. N., You, S. L., Wang, L. W., Wang, Q., Wu, D. M., and Santella, R. M. Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan. Carcinogenesis (Lond.), 22: 1289-1294, 2001.
12. Omer, R. E., Verhoef, L., Van't Veer, P., Idris, M. O., Kadaru, A. M., Kampman, E., Bunschoten, A., and Kok, F. J. Peanut butter intake, GSTM1 genotype and hepatocellular carcinoma: a case-control study in Sudan. Cancer Causes Control, 12: 23-32, 2001.
13. Tiemersma, E. W., Omer, R. E., Bunschoten, A., Van't Veer, P., Kok, F. J., Idris, M. O., Kadaru, A. M., Fedail, S. S., and Kampman, E. Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma. Cancer Epidemiol. Biomark. Prev., 10: 785-791, 2001.
14. Chen, S. Y., Wang, L. Y., Lunn, R. M., Tsai, W. Y., Lee, P. H., Lee, C. S., Ahsan, H., Zhang, Y. J., Chen, C. J., and Santella, R. M. Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls. Int. J. Cancer, 99: 14-21, 2002.
15. Chen, S. Y., Chen, C. J., Tsai, W. Y., Ahsan, H., Liu, T. Y., Lin, J. T., and Santella, R. M. Associations of plasma aflatoxin B1-albumin adduct level with plasma selenium level and genetic polymorphisms of glutathione S-transferase M1 and T1. Nutr. Cancer (Phila.), 38: 179-185, 2000.
16. Wong, N. A., Rae, F., Bathgate, A., Smith, C. A., and Harrison, D. J. Polymorphisms of the gene for microsomal epoxide hydrolase and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a Caucasian population. Toxicol. Lett., 115: 17-22, 2000.
17. Omiecinski, C. J., Aicher, L., Holubkov, R., and Checkoway, H. Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. Pharmacogenetics, 3: 150-158, 1993.
18. Evans, A. A., Chen, G., Ross, E. A., Shen, F. M., Lin, W. Y., and London, W. T. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol. Biomark. Prev., 11: 369-376, 2002.
19. Ueno, Y., Iijima, K., Wang, S. D., Sugiura, Y., Sekijima, M., Tanaka, T., Chen, C., and Yu, S. Z. Fumonisins as a possible contributory risk fact or for primary liver cancer: a 3-year study of corn harvested in Haimen, China, by HPLC and ELISA. Food Chem. Toxicol., 35: 1143-1150, 1997.
20. Ming, L., Thorgeirsson, S. S., Gail, M. H., Lu, P., Harris, C. C., Wang, N., Shao, Y., Wu, Z., Liu, G., Wang, X., and Sun, Z. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology, 36: 1214-1220.
21. Hassett, C., Aicher, L., Sidhu, J. S., and Omiecinski, C. J. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet., 3: 421-428, 1994.
22. Buetow, K. H., Edmonson, M. N., and Cassidy, A. B. Reliable identification of large numbers of candidate SNPs from public EST data. Nat. Genet., 21: 323-325, 1999.
23. Lemeshow, S., and Hosmer, D. W., Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am. J. Epidemiol., 115: 92-106, 1982.
24. Manenti, G., De Gregorio, L., Pilotti, S., Falvella, F. S., Incarbone, M., Ravagnani, F., Pierotti, M. A., and Dragani, T. A. Association of chromosome 12p genetic polymorphisms with lung adenocarcinoma risk and prognosis. Carcinogenesis (Lond.), 18: 1917-1920, 1997.
25. Wild, C. P., Yin, F., Turner, P. C., Chemin, I., Chapot, B., Mendy, M., Whittle, H., Kirk, G. D., and Hall, A. J. Environmental and genetic determinants of aflatoxin-albumin adducts in the Gambia. Int. J. Cancer, 86: 1-7, 2000.
26. Wild, C. P., Fortuin, M., Donato, F., Whittle, H. C., Hall, A. J., Wolf, C. R., and Montesano, R. Aflatoxin, liver enzymes, and hepatitis B virus infection in Gambian children. Cancer Epidemiol. Biomark. Prev., 2: 555-561, 1993.
27. Ahsan, H., Wang, L. Y., Chen, C. J., Tsai, W. Y., and Santella, R. M. Variability in aflatoxin-albumin adduct levels and effects of hepatitis B and C virus infection and glutathione S-transferase M1 and T1 genotype. Environ. Health Perspect., 109: 833-837, 2001.
28. Bian, J. C., Shen, F. M., Shen, L., Wang, T. R., Wang, X. H., Chen, G. C., and Wang, J. B. Susceptibility to hepatocellular carcinoma associated with null genotypes of GSTM1 and GSTT1. World J. Gastroenterol., 6: 228-230, 2000.
29. Kelly, E. J., Erickson, K. E., Sengstag, C., and Eaton, D. L. Expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae reveals a functional role in aflatoxin B1 detoxification. Toxicol. Sci., 65: 35-42, 2002.
30. Kroetz, D. L., and Zeldin, D. C. Cytochrome p450 pathways of arachidonic acid metabolism. Curr. Opin. Lipidol., 13: 273-283, 2002.
31. Farin, F. M., Janssen, P., Quigley, S., Abbott, D., Hassett, C., Smith-Weller, T., Franclin, G. M., Swanson, P. D., Longstreth, W. T., Jr., Omiecinski, C. J., and Checkoway, H. Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's disease. Pharmacogenetics, 11: 703-708, 2001.
32. Dragani, T. A., Manenti, G., and Della, P. G. Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice. Cancer Res., 51: 6299-6303, 1991.
33. Manenti, G., Binelli, G., Gariboldi, M., Canzian, F., De Gregorio, L., Falvella, F. S., Dragani, T. A., and Pierotti, M. A. Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice. Genomics, 23: 118-124, 1994.
34. Lee, G. H., and Drinkwater, N. R. The Hcr (hepatocarcinogen resistance) loci of DBA/2J mice partially suppress phenotypic expression of the Hcs (hepatocarcinogen sensitivity) loci of C3H/HeJ mice. Carcinogenesis (Lond.), 16: 1993-1996, 1995.
35. Lee, G. H., Bennett, L. M., Carabeo, R. A., and Drinkwater, N. R. Identification of hepatocarcinogen-resistance genes in DBA/2 mice. Genetics, 139: 387-395, 1995.
36. Drinkwater, N. R., and Ginsler, J. J. Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice. Carcinogenesis (Lond.), 7: 1701-1707, 1986.
37. Gariboldi, M., Manenti, G., Canzian, F., Falvella, F. S., Pierotti, M. A., Della, P. G., Binelli, G., and Dragani, T. A. Chromosome mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res., 53: 209-211, 1993.
38. Wogan, G. N. Metabolism and Biochemical Effects of Aflatoxins, in Aflatoxin-Scientific Background Control, and Implications. New York: Academic Press, Inc., 1969.
39. Quinn, B. A., Crane, T. L., Kocal, T. E., Best, S. J., Cameron, R. G., Rushmore, T. H., Farber, E., and Hayes, M. A. Protective activity of different hepatic cytosolic glutathione S-transferases against DNA-binding metabolites of aflatoxin B1. Toxicol. Appl. Pharmacol., 105: 351-363, 1990.
40. Vesselinovitch, S. D., Mihailovich, N., Wogan, G. N., Lombard, L. S., and Rao, K. V. Aflatoxin B1, a hepatocarcinogen in the infant mouse. Cancer Res., 32: 2289-2291, 1972.
41. Gong, Y. Y., Cardwell, K., Hounsa, A., Egal, S., Turner, P. C., Hall, A. J., and Wild, C. P. Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional study. BMJ, 325: 20-21, 2002.
42. Buetler, T. M., Slone, D., and Eaton, D. L. Comparison of the aflatoxin B1-8.9-epoxide conjugating activities of two bacterially expressed α class glutathione S-transferase isozymes from mouse and rat. Biochem. Biophys. Res. Commun., 188: 597-603, 1992.
43. McGlynn, K. A., Tsao, L., Hsing, A. W., Devesa, S. S., and Fraumeni, J. F., Jr. International trends and patterns of primary liver cancer. Int. J. Cancer, 94: 290-296, 2001.
44. Budowle, B, Masibay, A., Anderson, S. J., Barna, C., Biega, L., Brenneke, S., Brown, B. L., Cramer, J., DeGroot, G. A., Douglas, D., Duceman, B., Eastman, A., Giles, R., Hamill, J., Haase, D. J., Janssen, D. W., Kupferschmid, T. D., Lawton, T., Lemire, C., Llewellyn, B., Moretti, T., Neves, J., Palaski, C., Schueler, S., Sgueglia, J., Sprecher, C., Tomsey, C., and Yet, D. STR primer concordance study. Forensic Sci. Int., 124: 47-54, 2001.